The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1971, 107: 1666-1672.
Copyright © 1971 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müller-Eberhard, H. J.
Right arrow Articles by Fjellström, K.-E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Müller-Eberhard, H. J.
Right arrow Articles by Fjellström, K.-E.

Isolation of the Anticomplementary Protein from Cobra Venom and its Mode of Action on C31,2,

Hans J. Müller-Eberhard and Karl-Erik Fjellström

Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037

Abstract

Cobra factor, a protein of the venom of Naja naja, was isolated. It was characterized as a glycoprotein with a molecular weight of 144,000 and an electrophoretic mobility of a beta globulin at pH 8.6. Added to whole human serum it converted and inactivated C3. The effect on C3 was found to be dependent upon a non-complement plasma protein and on bivalent cations. To generate C3-directed enzymatic activity, cobra factor had to enter into a firm complex with the plasma protein, a 5S thermolabile beta pseudoglobulin.

Footnotes

1 This is publication number 509 from the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037.

2 This work was supported by United States Public Health Service Grant AI-07007 and United States Atomic Energy Commission Contract AT(04-3)-730.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Kolln, E. Spillner, J. Andra, K. Klensang, and R. Bredehorst
Complement Inactivation by Recombinant Human C3 Derivatives
J. Immunol., November 1, 2004; 173(9): 5540 - 5545.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Rawal and M. K. Pangburn
Functional Role of the Noncatalytic Subunit of Complement C5 Convertase
J. Immunol., February 1, 2000; 164(3): 1379 - 1385.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. C. Makrides
Therapeutic Inhibition of the Complement System
Pharmacol. Rev., March 1, 1998; 50(1): 59 - 88.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1971 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1971 by The American Association of Immunologists, Inc. All rights reserved.